We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA hit Vida International’s drug manufacturing facility in Taoyuan City, Taiwan with a warning letter for serious quality violations including inadequate drug testing.